PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.

Biomedicines · 2022 · PMC8869639 · PMID 35203508

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Two upper gastrointestinal (GI) adenocarcinomas (ESCA and STAD) exhibited superior OS and DFS according to PBK/TOPK expression (ESCA OS HR = 0.71, DFS HR = 0.8; STAD OS HR = 0.82, DFS HR = 0.62); however, they did not reach statistical significance ( Figure 1 A and Supplementary Figure S4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.